On October 15, Hims & Hers Health Inc. fell 5.09% in Regular Trading, trading at $28.1802/share, with turnover of $157 million.
The move coincided with investor focus on the company’s Australia expansion after it launched the Hers women’s health platform there, rebranding Juniper and broadening offerings into hair regrowth, menopause and perimenopause, and weight management following its earlier acquisition of Eucalyptus.
Background context is that management previously said international expansion and weight-management growth would keep gross margin below historical levels, while second-quarter profitability and free cash flow were also pressured by investment in overseas operations and weight-loss products, reinforcing market caution over near-term expansion costs despite the broader product rollout.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments